Modal Title
Course Description
Patients with red eyes commonly present to primary care providers as their point of entry into the healthcare system. Many primary care providers are less familiar with ocular disease than eye-care professionals and may feel uncomfortable managing these potentially sight-threatening conditions. This course will equip primary, urgent, and emergency care providers with the knowledge and competence needed to examine the eye, as well as diagnose, and manage four common causes of red eyes.
Intended Audience
- Physicians
- Physician Assistants
- Nurses
- APRNs
- Optometrists
Learning Objectives
At the completion of this activity, healthcare providers will be able to:
- Identify the major structures of the eye and the respective impact on vision
- Describe which ocular structures are most likely to cause common eye-related symptoms
- Describe the most important elements of a patient’s ocular history to help focus the exam and establish appropriate differentials
- List four common causes of red eyes in the primary care setting and explain how to differentiate these four causes based on patient history and clinical presentation
- Summarize the treatment for each of the four common causes of red eyes including potential pharmaceutical treatment and/or appropriate referral
Details
- Credit/Contact Hours
- 1.5
- Pharmacotherapy Hours
- 0.25
- Faculty
-
- Brianne Hobbs, OD, FAAO
Assistant Chief-Optometry Service, Salisbury VA HCS
- Brianne Hobbs, OD, FAAO
- Language
-
- English
- Release Date
- February 1, 2023
- Expiration Date
- February 1, 2026
- Instructional Methods
-
- Assessment Review with Rationale
- Case Studies
- Lesson Recall-Ungraded Self Assessment
- Video Narration
- Assessment
-
- Autograded and Quiz Retakes Allowed
- Daily CE Broker Reporting for Registered Boards
- Graded Final Quiz
- Passing 80%+
State/Local Approvals
- Approved/Accepted By
-
- Arkansas State Board of Nursing
- Bahamas Medical Council
- District of Columbia Board of Nursing
- Florida Board of Medicine
- Florida Board of Nursing
- Florida Board of Nursing - Certified Nursing Assistants
- Florida Board of Osteopathic Medicine
- Florida Council of Licensed Midwifery
- Florida Physician Assistants
- Georgia Board of Nursing
- Georgia Composite Medical Board - Physician Assistants
- Georgia Composite Medical Board - Physicians & Telemedicine
- Kansas State Board of Nursing
- Kentucky Board of Nursing
- Louisiana State Board of Medical Examiners - Physicians & Surgeons
- Michigan Board of Nursing
- Mississippi Board of Nursing
- Mississippi State Board of Medical Licensure
- New Hampshire Medical Society
- New Mexico Board of Nursing
- New Mexico Certified Nurse Midwives and Licensed Midwives
- New Mexico Medical Board
- Oklahoma Board of Medical Licensure and Supervision - Medical Doctors
- Oklahoma Board of Medical Licensure and Supervision - Physician Assistants
- South Carolina Board of Examiners in Optometry
- South Carolina Board of Medical Examiners
- South Carolina Board of Nursing
- State Medical Board of Ohio
- Tennessee Board of Medical Examiners
- Tennessee Board of Osteopathic Examination
- Texas Optometry Board
- West Virginia Board of Registered Nurses
- Wyoming Board of Nursing
CE Accreditation
- Accrediting CEs
-
Jointly provided by Partners for Advancing Clinical Education (PACE) and Premiere Education.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Premiere Education. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hour(s).
Designated for 0.25 contact hour(s) of pharmacotherapy credit for Advance Practice Registered Nurses.Physician Continuing Education
PACE designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
COPE Credit
Partners for Advancing Clinical Education is accredited by COPE to provide continuing education to optometrists.
Credit Statement: This course is COPE approved for 1.5 hour(s) of CE credit. Activity #125437 and Course ID 8289-TD. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure.
- Instructions for CE Credit
-
Participation in this self-study activity should be completed in approximately 1.5 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps during the period from February 1, 2023 through February 1, 2026:
- Review objectives and disclosures
- Study the educational content
- Successfully complete activity assessment(s)
- Complete the activity evaluation
You must receive an assessment score of at least 80% and respond to all evaluation questions to receive a certificate.
Disclosures
- Disclosures
-
Disclosure of Conflicts of Interest
PACE requires planners, faculty, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Faculty: The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies:
-
Brianne Hobbs, OD, FAAO
Assistant Chief-Optometry Service, Salisbury VA HCS
• has no relevant financial relationships with ineligible companies to disclose
Planners & Managers & Translators: The PACE & Premiere Education planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
-
Brianne Hobbs, OD, FAAO